JP2007513993A5 - - Google Patents

Download PDF

Info

Publication number
JP2007513993A5
JP2007513993A5 JP2006544438A JP2006544438A JP2007513993A5 JP 2007513993 A5 JP2007513993 A5 JP 2007513993A5 JP 2006544438 A JP2006544438 A JP 2006544438A JP 2006544438 A JP2006544438 A JP 2006544438A JP 2007513993 A5 JP2007513993 A5 JP 2007513993A5
Authority
JP
Japan
Prior art keywords
patient
ciclesonide
aqueous suspension
sterile aqueous
clinical condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006544438A
Other languages
English (en)
Japanese (ja)
Other versions
JP5001657B2 (ja
JP2007513993A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/053495 external-priority patent/WO2005058935A2/en
Publication of JP2007513993A publication Critical patent/JP2007513993A/ja
Publication of JP2007513993A5 publication Critical patent/JP2007513993A5/ja
Application granted granted Critical
Publication of JP5001657B2 publication Critical patent/JP5001657B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006544438A 2003-12-16 2004-12-15 噴霧化用のシクレソニドの水性懸濁液 Expired - Lifetime JP5001657B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03028848 2003-12-16
EP03028848.4 2003-12-16
PCT/EP2004/053495 WO2005058935A2 (en) 2003-12-16 2004-12-15 Aqueous suspensions of ciclesonide for nebulisation

Publications (3)

Publication Number Publication Date
JP2007513993A JP2007513993A (ja) 2007-05-31
JP2007513993A5 true JP2007513993A5 (enExample) 2008-01-24
JP5001657B2 JP5001657B2 (ja) 2012-08-15

Family

ID=34684543

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006544438A Expired - Lifetime JP5001657B2 (ja) 2003-12-16 2004-12-15 噴霧化用のシクレソニドの水性懸濁液

Country Status (21)

Country Link
US (2) US20070117783A1 (enExample)
EP (2) EP1697398B1 (enExample)
JP (1) JP5001657B2 (enExample)
KR (1) KR101086095B1 (enExample)
CN (1) CN100513417C (enExample)
AR (1) AR046892A1 (enExample)
AU (1) AU2004298447B2 (enExample)
BR (1) BRPI0416854B8 (enExample)
CA (1) CA2549038C (enExample)
CO (1) CO5700832A2 (enExample)
EA (1) EA012388B1 (enExample)
EC (1) ECSP066608A (enExample)
IL (1) IL175461A (enExample)
MY (1) MY159377A (enExample)
NO (1) NO337225B1 (enExample)
NZ (1) NZ547217A (enExample)
PE (1) PE20050941A1 (enExample)
TW (1) TWI350757B (enExample)
UA (1) UA87123C2 (enExample)
WO (1) WO2005058935A2 (enExample)
ZA (1) ZA200603768B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2022796A1 (en) * 2007-08-07 2009-02-11 Nycomed GmbH Amorphous ciclesonide
US7984792B2 (en) * 2008-03-03 2011-07-26 Rolls-Royce Corporation Lubrication system
CN102238958A (zh) * 2008-12-03 2011-11-09 日本株式会社Ltt生物医药 含有修饰型超氧化物歧化酶的吸入剂
EP3311823B1 (en) 2009-09-02 2020-11-25 Synedgen, Inc. Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
DK2670242T3 (da) * 2011-01-31 2022-05-02 Avalyn Pharma Inc Aerosolpirfenidon- og pyridonanalogforbindelser og anvendelser deraf
US10105356B2 (en) 2011-01-31 2018-10-23 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
KR20140057604A (ko) 2011-08-12 2014-05-13 베링거잉겔하임베트메디카게엠베하 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
WO2013024070A1 (en) 2011-08-18 2013-02-21 Nycomed Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation
EP2756840B1 (en) 2011-09-14 2020-08-19 Shionogi & Co., Ltd. Pharmaceutical composition for inhalation
LT3473255T (lt) 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Farmacinė vaisto forma, apimanti ciklezonidą
BR122016029247A2 (pt) * 2012-12-21 2019-08-20 Boehringer Ingelheim Vetmedica Gmbh Ciclesonida para o tratamento de doença das vias respiratórias em cavalos e composição que a compreende
AU2015204558B2 (en) 2014-01-10 2020-04-30 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
HUE051527T2 (hu) 2014-06-18 2021-03-01 Boehringer Ingelheim Vetmedica Gmbh Muszkarin-antagonisták és kombinációik légúti betegség lovakban történõ kezelésére
WO2016040899A1 (en) * 2014-09-11 2016-03-17 Synedgen, Inc. Compositions and methods of use thereof
WO2017022814A1 (ja) * 2015-08-05 2017-02-09 第一三共株式会社 ネブライザー用組成物
CN106692163A (zh) * 2015-11-13 2017-05-24 天津金耀集团有限公司 一种吸入用环索奈德混悬液组合物
WO2019090405A1 (pt) * 2017-11-11 2019-05-16 Carvalho Junior Mario Virgilio De Medicamento de ciclesonida para cura e prevenção da gripe causada pelo vírus influenza
US20220023282A1 (en) * 2018-12-13 2022-01-27 Mannkind Corporation Compositions of Bedaquiline, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods of Treatment Comprising Them
US20210346613A1 (en) * 2020-05-05 2021-11-11 Mahesh Kumar KHAITAN Controlled delivery device for treating coronavirus infections and methods thereof
CN115835885B (zh) * 2020-06-23 2025-02-07 广州谷森制药有限公司 包含奥达特罗和布地奈德的药物组合物的制备
US20240358888A1 (en) * 2021-04-01 2024-10-31 Vitrean Inc. Methods for manufacturing of highly concentrated hydrogels
WO2022231533A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE458986B (sv) * 1985-03-29 1989-05-29 Draco Ab Dosfoerpackning
SE8600632D0 (sv) 1986-02-13 1986-02-13 Kabivitrum Ab Novel pharmaceutical composition
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
US5346702A (en) * 1992-12-04 1994-09-13 Sterling Winthrop Inc. Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
UA45311C2 (uk) * 1993-04-02 2002-04-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх 16<font face="Symbol">a</font>,17-ЦИКЛОГЕКСИЛМЕТИЛЕНДІОКСИ-11<font face="Symbol">b</font>,21-ДИГІДРОКСИПРЕГНА-1,4-ДІЄН-3,20-ДІОН, СПОСІБ ЙОГО ОДЕРЖАННЯ, ЛІКАРСЬКИЙ ЗАСІБ
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
GB9410222D0 (en) 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
DE19635498A1 (de) 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
DE69914742T2 (de) 1998-05-29 2004-11-25 Skyepharma Canada Inc., Verdun Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
IT1303692B1 (it) 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
EP1142565A4 (en) 1999-10-20 2004-03-17 Teijin Ltd AQUEOUS THERAPEUTIC COMPOSITIONS
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020183292A1 (en) * 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
DK1337279T3 (da) * 2000-11-24 2006-09-25 Breath Ltd Sterilisation af glucocorticosteroidsuspensioner
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
DE10145361A1 (de) * 2001-09-14 2003-04-03 Pari Gmbh Verfahren zur Herstellung von flüssigen, sterilen Zubereitungen zur Inhalation
EP1438019A1 (en) * 2001-10-24 2004-07-21 PARI GmbH Spezialisten für effektive Inhalation Kit for the preparation of a pharmaceutical composition
US8541399B2 (en) 2002-02-19 2013-09-24 Resolution Chemicals Limited Solvent-based sterilisation of pharmaceuticals
ATE352564T1 (de) 2002-03-04 2007-02-15 Nymox Corp Spheron-komponenten für die bestimmung von verbindungen, die symptome der alzheimer krankheit behandeln können, ihre behandlungen und tiermodelle
JP4720086B2 (ja) 2002-04-12 2011-07-13 味の素株式会社 動脈硬化予防用組成物
ITMI20020808A1 (it) 2002-04-17 2003-10-17 Chiesi Farma Spa Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
JP4364486B2 (ja) 2002-07-02 2009-11-18 帝人株式会社 無菌水性懸濁製剤
HK1080365B (zh) 2002-07-02 2008-11-28 Astrazeneca Ab 含有环索奈德的无菌水性混悬剂
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
PT1545548E (pt) * 2002-08-30 2010-09-02 Nycomed Gmbh Utilização da combinação de ciclesonida e anti-histamínicos para o tratamento de rinite alérgica
WO2004029574A1 (ja) 2002-09-24 2004-04-08 Fujitsu Limited 歪み波形制御装置、歪み規制部材、歪み波形制御装置の歪み波形制御方法、及び歪み波形制御プログラム
JP2006501936A (ja) 2002-10-04 2006-01-19 エラン ファーマ インターナショナル,リミティド 固体ナノ粒子活性薬剤のガンマ線照射
ITMI20022674A1 (it) * 2002-12-18 2004-06-19 Chiesi Farma Spa Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.
EP1454636A1 (en) 2003-03-04 2004-09-08 Dompé S.P.A. Sterilization of glucocorticoid drug particles for pulmonary delivery
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
PT1670482E (pt) * 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
DE10347994A1 (de) * 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Wässrige Aerosol-Zubereitung
DE602005026225D1 (de) 2004-03-12 2011-03-24 Cipla Ltd Sterilisationsprozess für Steroide
GB0410995D0 (en) 2004-05-17 2004-06-23 Norton Healthcare Ltd Heat sterilization of glucocorticosteroids
ITSA20040012A1 (it) 2004-09-07 2004-12-07 Genetec S P A Processo di sterilizzazione di un glucocorticosteroide.
GB0425266D0 (en) 2004-11-16 2004-12-15 Norton Healthcare Ltd Pharmaceutical manufacturing process

Similar Documents

Publication Publication Date Title
JP2007513993A5 (enExample)
JP2022009125A5 (enExample)
JP2007106777A5 (enExample)
AR068901A1 (es) Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos
WO2005058935A3 (en) Aqueous suspensions of ciclesonide for nebulisation
JP2007516193A5 (enExample)
PL3006022T3 (pl) Osmolity do leczenia wirusowych chorób układu oddechowego
Griese et al. Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis
CN208551902U (zh) 鼻腔支架
JP2007119497A5 (enExample)
CN101757405A (zh) 清肺汤
JP2011500589A5 (enExample)
CN204092823U (zh) 一种多疗效儿科肛门扩张器
CN103027952A (zh) 用于预防流感的中药香囊
CN201565010U (zh) 一种鼻塞灭菌器
JP2003522147A5 (enExample)
CN203577086U (zh) 呃逆治疗装置
CN103028074A (zh) 用于预防儿童感冒的中药香囊
CN204106297U (zh) 防打鼾鼻腔塞
JP2017511307A5 (enExample)
RU2004121780A (ru) Способ лечения
JP2004513150A5 (enExample)
Ghofrani et al. The effect of the soluble guanylate cyclase stimulator Riociguat on hemodynamics in patients with pulmonary hypertension due to chronic obstructive pulmonary disease
CN102058941A (zh) 一种鼻塞灭菌器
CN205924427U (zh) 一种集成式中医按摩袋